Dr. Chandra Belani on Selecting Anti-PD-L1 Agents in Lung Cancer
Chandra P. Belani, MD, deputy director, Penn State Hershey Cancer Institute, Miriam Beckner Distinguished Professor of Medicine, Penn State Hershey College of Medicine, discusses results seen with anti–PD-1/PD-L1 treatments in lung cancer.
Chandra P. Belani, MD, deputy director, Penn State Hershey Cancer Institute, Miriam Beckner Distinguished Professor of Medicine, Penn State Hershey College of Medicine, discusses results seen with anti—PD-1/PD-L1 treatments in lung cancer.
Belani says at this juncture, there is no one “winner" amongst these treatments.
Identifying a group of patients that best benefit from anti—PD-1 treatments will be the key to better understanding these agents, says Belani.
Related Videos
Related Content
